Correlation Between Cardio Diagnostics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Transcode Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Transcode Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Transcode Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cardio and Transcode is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Transcode Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to generate 1.37 times more return on investment than Transcode Therapeutics. However, Cardio Diagnostics is 1.37 times more volatile than Transcode Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 6.17 in Cardio Diagnostics Holdings on January 1, 2025 and sell it today you would lose (2.18) from holding Cardio Diagnostics Holdings or give up 35.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 85.71% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Transcode Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| Transcode Therapeutics |
Cardio Diagnostics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Transcode Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Cardio Diagnostics vs. Cardio Diagnostics Holdings | ||
| Cardio Diagnostics vs. Revelation Biosciences | ||
| Cardio Diagnostics vs. LMF Acquisition Opportunities | ||
| Cardio Diagnostics vs. OmniAb Inc |
| Transcode Therapeutics vs. Xenetic Biosciences | ||
| Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | ||
| Transcode Therapeutics vs. Eyenovia | ||
| Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |